Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Travere Therapeutics, Inc. (NASDAQ:TVTX) is losing a “ton of money.”
Travere Therapeutics will report third-quarter financial results before the opening bell on Thursday, Oct. 31. Analysts expect the company to report a quarterly loss of 66 cents per share, compared to a year-ago profit of $1.97 per share.
“There is no level that the buyers won't take this stock higher. So I'm going to tell you that I would hold on to it as a spec and let them walk it up,” Cramer said when asked about Palantir Technologies Inc. (NYSE:PLTR).
Don’t Miss:
Commercial real estate has historically outperformed the stock market, and this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!
If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it?
Palantir Technologies will release results for its third quarter ended Sept. 30, on Monday, Nov. 4, after the closing bell. Analysts expect the company to report quarterly earnings at 9 cents per share, up from 7 cents per share in the year-ago period. The company projects to report revenue of $701.13 million for the quarter.
“I don't think Stanley Black & Decker (NYSE:SWK) is going to give you a discouraging forecast,” Cramer said.
On Tuesday, Stanley Black & Decker said its board of directors approved a regular fourth quarter cash dividend of 82 cents per common share. The company also appointed John L. Garrison, Jr, former chairman, president, and chief executive officer of Terex Corporation to its board of directors.
Lower interest rates mean some investments won't yield what they did in months past, but you don't have to lose those gains. Certain private market real estate investments are giving retail investors the opportunity to capitalize on these high-yield opportunities.